Mark Davies MSc, BSc

Mark is the VP Biomedical Informatics at BenevolentAI. He has a background in molecular genetics, bioinformatics (BSc University of Sussex) and computer science (MSc Birkbeck College) and has over 15 years of experience working on biomedical data representation, data analysis and application development. In 2001, he joined the London based biotechnology company Inpharmatica, where he was initially working on mining the output of the Human Genome Project and eventually moved on to building chemogenomics and druggability assessment systems used by pharmaceutical companies, such as Bayer. Mark moved to the European Bioinformatics Institute (EMBL-EBI), as one of the founding members and technical lead for the ChEMBL database, the largest open-source Structure Activity Relationship (SAR) database. Mark was also responsible for the successful transition of the SureChEMBL chemical patent system from Digital Science to the EMBL-EBI.